[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"condition:hyperphosphatemia":3},{"name":4,"total":5,"recruiting":5,"trials":6,"biomarkers":28,"states":29},"Hyperphosphatemia",3,[7,15,22],{"nct_id":8,"title":9,"phases":10,"status":12,"updated_at":13,"content_modified":14},"NCT06933472","A Study of a Novel Iron-based Phosphate Binder AP301 in Patients With Hyperphosphatemia in the U.S. and China",[11],"Phase 3","RECRUITING","2026-08-26T02:16:54.876240Z","2026-05-05T02:43:27.918814Z",{"nct_id":16,"title":17,"phases":18,"status":12,"updated_at":20,"content_modified":21},"NCT06712654","A Study to Evaluate Safety, Tolerability and Efficacy of AP306 at Fixed Doses in Dialysis Participants With Hyperphosphatemia",[19],"Phase 2","2026-08-26T02:15:40.343619Z","2026-05-29T15:36:40.170026Z",{"nct_id":23,"title":24,"phases":25,"status":12,"updated_at":26,"content_modified":27},"NCT04278404","Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS)",[],"2026-08-26T02:19:13.549512Z","2026-05-13T02:55:06.246558Z",[],[30,33,36,39,42,45],{"state":31,"count":5,"slug":32},"California","california",{"state":34,"count":5,"slug":35},"Colorado","colorado",{"state":37,"count":5,"slug":38},"Florida","florida",{"state":40,"count":5,"slug":41},"New Mexico","new-mexico",{"state":43,"count":5,"slug":44},"Ohio","ohio",{"state":46,"count":5,"slug":47},"Texas","texas"]